In silico analysis demonstrates that HBPs may have a role in periodontal disease and can be used for identifying potential drug targets that include chemokines, CXCL12, and proteases, MMP-2 and -9, for regulating periodontitis. This evidence concerns the gene CXCL12 and periodontitis.